関連する実験動画

Updated: Sep 9, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

心血管疾患に対する長い非コーディングRNAベースの治療法

Noelia Bellon Quinones^1,2, Ruggero Belluomo^3,4, Rio P Juni^5,6

¹Institute for Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University, Frankfurt Am Main, Germany.

Journal of cardiovascular translational research

|September 3, 2025

まとめ

長い非コーディングRNA (lncRNAs) は,心血管疾患 (CVD) の主要な調節因子である. 研究ではバイオマーカーや治療標的としての可能性が示され進歩した遺伝子治療は将来の治療に有望であることを示しています

科学分野:

分子生物学
心血管研究
遺伝学

背景:

心血管疾患 (CVD) は世界の主要な健康問題であり,新しい治療方法の必要性を引き起こしています.
長い非コーディングRNA (lncRNAs) は,心臓血管の健康と疾患に関連する細胞過程における遺伝子発現の重要な調節体としてますます認識されています.

研究の目的:

心血管疾患の病原性における lncRNA の機能的役割を検討する.
lncRNAの診断用バイオマーカーおよび治療用ターゲットとしての可能性を調査する.
lncRNAベースの心臓血管治療の遺伝子療法と投与戦略の進歩について議論する.

主な方法:

心血管疾患における lncRNA機能に関する研究の文献レビュー.
現在のRNAターゲティング技術 (例えば,反意味オリゴヌクレオチド,siRNA,CRISPR) の分析.
lncRNA療法のためのウイルスおよび非ウイルス輸送システムの評価.

主要な成果:

lncRNAsは,高縮,線維症,炎症,血管再構成を含む主要なCVDプロセスに関与しています.
新興のRNAターゲティング技術は心血管疾患の治療の可能性を秘めています
lncRNAベースの治療法の臨床翻訳には,特に投与方法に関する課題が残っています.

結論:

lncRNAは心臓血管疾患の新たな診断と治療戦略を開発する有望な分野です.
lncRNAの生物学と伝達システムの最適化に関するさらなる研究は,臨床応用に不可欠である.
lncRNAベースの治療は心血管医学を大幅に進歩させる可能性を秘めています

キーワード:

心血管疾患遺伝子療法長い非コーディングRNA (lncRNAs)RNA療法

さらに関連する動画

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

関連する概念動画

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...